33510 Federal Register / Vol. 61, No. 125 / Thursday, June 27, 1996 / Notices

1Copies of the Consent Order and Set Aside

Order are available from the Commission’s Public

Reference Branch, H–130, 6th Street and

Pennsylvania Avenue, N.W., Washington, D.C.

20580.

1Copies of the Consent Order and Set Aside

Order are available from the Commission’s Public

Reference Branch, H–130, 6th Street and

Pennsylvania Avenue, NW., Washington, DC 20580.

1Copies of the Complaint and the Decision and

Order are available from the Commission’s Public

Reference Branch, H–130, 6th Street & Pennsylvania

Avenue, NW., Washington, DC 20580.

1Copies of the Modifying Order and

Commissioner Azcuenaga’s statement are available

from the Commission’s Public Reference Branch,

H–130, 6th Street and Pennsylvania Avenue, N.W.,

Washington, D.C. 20580.

prior approval provisions in outstanding

merger orders and making them

consistent with the policy.

DATES: Consent order issued June 13,

1989. Set aside order issued October 31,

1995.1

FOR FURTHER INFORMATION CONTACT:

Elizabeth Piotrowski, FTC/S–2115,

Washington, D.C. 20580. (202) 326–

2623.

SUPPLEMENTARY INFORMATION: In the

Matter of KKR Associates, L.P. The

prohibited trade practices and/or

corrective actions are removed as

indicated.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret

or apply sec. 5, 38 Stat. 719, as amended; sec.

7, 38 Stat. 731, as amended; 15 U.S.C. 45, 18)

Donald S. Clark,

Secretary.

[FR Doc. 96–16480 Filed 6–26–96; 8:45 am]

BILLING CODE 6750–01–M

[Docket C–3378]

Mannesmann, A.G.; Prohibited Trade

Practices and Affirmative Corrective

Actions

AGENCY: Federal Trade Commission.

ACTION: Set aside order.

SUMMARY: This order reopens a 1992

consent order—which required

Mannesmann to divest the Buschman

Co. and to obtain, for 10 years,

Commission approval prior to acquiring

any business that manufactures and

sells certain conveyor systems—and sets

aside the consent order pursuant to the

Commission’s Prior Approval Policy

Statement. The order cites the

availability of the premerger notification

and waiting period requirements, and

noted that under the Policy Statement,

the Commission presumes that the

public interest requires setting aside the

prior approval requirement in Paragraph

V of the order.

DATES: Consent Order issued March 24,

1992. Set aside order issued October 11,

1995.1

FOR FURTHER INFORMATION CONTACT:

Ann Malester, FTC/S–2308,

Washington, DC 20580. (202) 326–2682.

SUPPLEMENTARY INFORMATION: In the

Matter of Mannesmann, A.G. The

prohibited trade practices and/or

corrective actions are removed as

indicated.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret

or apply sec. 5, 38 Stat. 719, as amended; sec.

7, 38 Stat. 731, as amended; 15 U.S.C. 45, 18)

Donald S. Clark,

Secretary.

[FR Doc. 96–16481 Filed 6–26–96; 8:45 am]

BILLING CODE 6750–01–M

[Docket C–3646]

Service Corporation International;

Prohibited Trade Practices, and

Affirmative Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent order.

SUMMARY: In settlement of alleged

violations of Federal law prohibiting

unfair or deceptive acts or practices and

unfair methods of competition, this

consent order permits Service

Corporation International (SCI), the

largest owner of funeral homes in North

America, to acquire Gilbraltar

Mausoleum Corporation and requires

SCI, among other things, to divest,

within 12 months, a number of

properties, including assets in Amarillo,

Texas, and Brevard and Lee Counties,

Florida, to Commission-approved

acquirers. In addition, the consent order

requires SCI, for 10 years, to notify the

Commission before acquiring certain

similar assets in any of these markets.

DATES: Complaint and Order issued

March 21, 1996.1

FOR FURTHER INFORMATION CONTACT:

Harold Kirtz, Federal Trade

Commission, Atlanta Regional Office,

1718 Peachtree St., NW., Room 1000,

Atlanta, GA. 30367. (404) 347–4837.

SUPPLEMENTARY INFORMATION: On Friday,

January 19, 1996, there was published

in the Federal Register, 61 FR 1512, a

proposed consent agreement with

analysis In the Matter of Service

Corporation International, for the

purpose of soliciting public comment.

Interested parties were given sixty (60)

days in which to submit comments,

suggestions or objections regarding the

proposed form of the order.

No comments having been received,

the Commission has ordered the

issuance of the complaint in the form

contemplated by the agreement, made

its jurisdictional findings and entered

an order to divest, as set forth in the

proposed consent agreement, in

disposition of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret

or apply sec. 5, 38 Stat. 719, as amended; sec.

7, 38 Stat. 731, as amended; 15 U.S.C. 45, 18)

Donald S. Clark,

Secretary.

[FR Doc. 96–16482 Filed 6–26–96; 8:45 am]

BILLING CODE 6750–01–M

[Dkt. C–3478]

The Valspar Corporation, et al.,

Prohibited Trade Practices and

Affirmative Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Modifying order.

SUMMARY: The order reopens a 1994

consent order that settled allegations

that Valspar’s acquisition of the Resin

Products Division of Cargill, Inc. would

eliminate competition between two

leading U.S. producers of coating resins.

This order modifies the consent order

by deleting the prior approval

requirements in Paragraphs VI and VII

pursuant to the Commission’s Prior

Approval Policy, under which the

Commission presumes that the public

interest requires reopening prior

approval provisions in outstanding

merger orders and making them

consistent with the policy.

DATES: Consent order issued January 25,

1994. Modifying order issued August

29, 1995.1

FOR FURTHER INFORMATION CONTACT:

Daniel Ducore, FTC/S–2115,

Washington, D.C. 20580. (202) 326–

2526.

SUPPLEMENTARY INFORMATION: In the

matter of The Valspar Corporation, et al.

The prohibited trade practices and/or

corrective actions as set forth at 59 FR

11610, are changed, in part, as indicated

in the summary.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret

or apply sec. 5, 38 Stat. 719, as amended; sec.

7, 38 Stat. 731, as amended; 15 U.S.C. 45, 18)

Donald S. Clark,

Secretary.

[FR Doc. 96–16483 Filed 6–26–96; 8:45 am]

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Public Health Service; Commission on

Dietary Supplement Labels

AGENCY: Office of Public Health and

Science, Office of Disease Prevention

and Health Promotion.
Federal Register / Vol. 61, No. 125 / Thursday, June 27, 1996 / Notices 33511

ACTION: Extension of Comment Period.

SUMMARY: The Department of Health and

Human Services (HHS) is providing

notice of an extension of the time

deadline for submission of written

comments.

DATES: Written comments on the scope

and intent of the Commission’s

objectives must be received by 5:00 p.m.

E.D.T. on August 30, 1996.

ADDRESSES: Kenneth D. Fisher, Ph.D.,

Executive Director, Commission on

Dietary Supplement Labels, Office of

Disease Prevention and Health

Promotion, Room 738G, Hubert H.

Humphrey Building, 200 Independence

Ave., SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT:

Kenneth D. Fisher, Ph.D., (202) 690–

7102.

SUPPLEMENTARY INFORMATION: Public

Law 103–417, Section 12, authorized

the establishment of a Commission on

Dietary Supplement Labels whose seven

members have been appointed by the

President. The appointments to the

Commission by the President and the

establishment of the Commission by the

Secretary of Health and Human Services

reflect the commitment of the President

and the Secretary to the development of

a sound and consistent regulatory policy

on labeling of dietary supplements.

The Commission is charged with

conducting a study and providing

recommendations for regulation of label

claims and statements for dietary

supplements, including the use of

supplemental literature in connection

with their sale and, in addition,

procedures for evaluation of label

claims. The Commission is expected to

evaluate how best to provide truthful,

scientifically valid, and non-misleading

information to consumers in order that

they may make informed health care

choices for themselves and their

families. The Commission’s study report

may include recommendations on

legislation, if appropriate and necessary.

Notices announcing meetings of the

Commission on Dietary Supplement

Labels were published on February 1,

1996 (61 FR 3714), February 1, 1996 (61

FR 3714), February 23, 1996 (61 FR

7005), March 29, 1996 (61 FR 14102),

April 4, 1996 (61 FR 15076), and May

16, 1996 (61 FR 24798). Each notice also

indicated that written comments on the

tasks of the Commission were due on

June 30, 1996. This notice is to provide

an extension of the deadline for

receiving comments.

Dated: June 13, 1996.

Claude Earl Fox,

Deputy Assistant Secretary for Health

(Disease Prevention and Health Promotion).

[FR Doc. 96–16405 Filed 6–26–96; 8:45 am]

BILLING CODE 4160–17–M

Agency for Toxic Substances and

Disease Registry

[ATSDR–110]

Minimal Risk Levels for Priority

Substances and Guidance for

Derivation; Republication

Editorial Note: The document set forth

below was originally published at 61 FR

25873, May 23, 1996, and is reprinted

because of typesetting errors.

AGENCY: Agency for Toxic Substances

and Disease Registry (ATSDR),

Department of Health and Human

Services (HHS).

ACTION: Notice.

SUMMARY: The Comprehensive

Environmental Response,

Compensation, and Liability Act

(CERCLA) (42 U.S.C. 9604 et seq.), as

amended by the Superfund

Amendments and Reauthorization Act

(SARA) (Pub. L. 99–499), requires that

ATSDR develop jointly with the U.S.

Environmental Protection Agency

(EPA), in order of priority, a list of

hazardous substances most commonly

found at facilities on the CERCLA

National Priorities List (NPL) (42 U.S.C.

9604(i)(2)); prepare toxicological

profiles for each substance included on

the priority list of hazardous substances,

and to ascertain in the toxicological

profiles, significant human exposure

levels (SHELs) for hazardous substances

in the environment, and the associated

acute, subacute, and chronic health

effects (42 U.S.C. 9604(i)(3)); and assure

the initiation of a research program to

fill identified data needs associated with

the substances (42 U.S.C. 9604(i)(5)).

The ATSDR Minimal Risk Levels

(MRLs) were developed in response to

the mandate for SHELs and to provide

screening levels for health assessors and

other responders to identify

contaminants and potential health

effects that may be of concern at

hazardous waste sites and releases.

This notice announces the internal

guidance for derivation of MRLs for

priority hazardous substances by

ATSDR. The guidance represents the

agency’s current approach to deriving

MRLs and reflects the most current

scientific assessment. Comments from

the public on the process of deriving

MRLs are welcome. The MRLs for a

particular substance are published in

the toxicological profile for that

substance. A listing of the current

published MRLs is provided at the end

of the notice.

ADDRESSES: Comments on this notice

should bear the docket control number

ATSDR–110 and should be submitted

to: Division of Toxicology, Agency for

Toxic Substances and Disease Registry,

Mailstop E–29, 1600 Clifton Road, NE.,

Atlanta, Georgia 30333.

FOR FURTHER INFORMATION CONTACT: Dr.

Selene Chou, Division of Toxicology,

Agency for Toxic Substances and

Disease Registry, 1600 Clifton Road,

NE., Mailstop E–29, Atlanta, Georgia

30333, telephone (404)639–6308 or FAX

(404)639–6315.

SUPPLEMENTARY INFORMATION: CERCLA

requires that ATSDR prepare

toxicological profiles for priority

hazardous substances, and to ascertain

significant human exposure levels for

these substances in the environment,

and the associated acute, subacute, and

chronic health effects (42 U.S.C.

9604(i)(3)). Minimal Risk Levels (MRLs)

were developed as an initial response to

the mandate. Following discussions

with scientists within the HHS and the

EPA, ATSDR chose to adopt a practice

similar to that of the EPA’s Reference

Dose (RfD) and Reference Concentration

(RfC) for deriving substance-specific

levels. An MRL is an estimate of the

daily human exposure to a hazardous

substance that is likely to be without

appreciable risk of adverse noncancer

health effects over a specified duration

of exposure. These substance- specific

estimates, which are intended to serve

as screening levels, are used by ATSDR

health assessors and other responders to

identify contaminants and potential

health effects that may be of concern at

hazardous waste sites and releases. It is

important to note that MRLs are not

intended to define clean-up or action

levels for ATSDR or other Agencies.

The toxicological profiles include an

examination, summary, and

interpretation of available toxicological

information and epidemiologic

evaluations of a hazardous substance.

During the development of toxicological

profiles, MRLs are derived when

ATSDR determines that reliable and

sufficient data exist to identify the target

organ(s) of effect, or the most sensitive

health effect(s) for a specific exposure

duration for a given route of exposure to

the substance. MRLs are based on

noncancer health effects only and are

not based on a consideration of cancer

effects. Inhalation MRLs are exposure

concentrations expressed in units of

parts per million (ppm) for gases and

volatiles, or milligrams per cubic meter